Cc1cc(CNCCN(C)C)c(C)n1-c1cc(S(=O)(=O)N2CCOCC2)ccc1N1CCCC1.O=C(O)C(=O)O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?